Glucotrack Inc (GCTK)

$4.49 -0.01 (-0.22%)
Market Cap 4.10M
Revenue (ttm) 0.00
Net Income (ttm) -22.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.19
Volume 5,200
Avg Vol 51,334
Day's Range N/A - N/A
Shares Out 911,000.00
Stochastic %K 6%
Beta 0.30
Analysts Strong Buy
Price Target N/A

Company Profile

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 842 7715
Address:
301 Route 17 North, Suite 800, Rutherford, United States
BillionerOfKing
BillionerOfKing Dec. 25 at 3:05 AM
$GCTK Current Stock Price: $4.49
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 24 at 12:40 PM
$GCTK will need u shortly * due to MWG shenanigans im pullingall mornign with beloved
0 · Reply
Stay_Tuned_
Stay_Tuned_ Dec. 23 at 1:09 PM
$GCTK I was a believer. Maybe still am but they need money in Q1, time running short for this to pop before needed dilution. Out for now will watch from sidelines.
0 · Reply
FullPorrtDipz
FullPorrtDipz Dec. 23 at 2:02 AM
If you like getting in them before the massive moves.. Drop @MomentumZeus a FOLLOW below. He's been calling some insane runners lately.. 🚀 Always buying positions on $GCTK $SNTI $RUBI $CTM
0 · Reply
FloatGlowCore_1416
FloatGlowCore_1416 Dec. 16 at 12:34 PM
$GCTK microcap biotech, narrow range and low float, one decent data point plus volume can send it
0 · Reply
Joby099
Joby099 Dec. 11 at 11:50 PM
$BDRX $AFJK $GCTK $ATGL $SOUN
0 · Reply
Tradr1205
Tradr1205 Dec. 11 at 3:05 PM
$GCTK Bought some more in premarket at $5.61. This baby is going to explode!
1 · Reply
Joby099
Joby099 Dec. 11 at 2:09 PM
$BDRX $AFJK $GCTK $ATGL $SOUN
0 · Reply
Jingbob
Jingbob Dec. 11 at 11:46 AM
$GCTK keep buying, the squeeze is coming
2 · Reply
BLD33
BLD33 Dec. 11 at 9:11 AM
$GCTK no shares to Short Cover coming !!!
1 · Reply
Latest News on GCTK
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

Nov 13, 2025, 4:05 PM EST - 5 weeks ago

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

Glucotrack, Inc. Encourages Shareholders to Vote

Nov 3, 2025, 4:05 PM EST - 7 weeks ago

Glucotrack, Inc. Encourages Shareholders to Vote

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Oct 29, 2025, 4:05 PM EDT - 2 months ago

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Glucotrack, Inc. Reminds Shareholders to Vote

Oct 28, 2025, 8:00 AM EDT - 2 months ago

Glucotrack, Inc. Reminds Shareholders to Vote

Glucotrack to Participate in the Q3 Virtual Investor Summit

Sep 11, 2025, 8:00 AM EDT - 3 months ago

Glucotrack to Participate in the Q3 Virtual Investor Summit

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 14, 2025, 4:05 PM EDT - 4 months ago

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Aug 6, 2025, 8:30 AM EDT - 5 months ago

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Jul 31, 2025, 8:30 AM EDT - 5 months ago

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Glucotrack Announces Repurchase of Series A Warrants

Jul 8, 2025, 8:30 AM EDT - 6 months ago

Glucotrack Announces Repurchase of Series A Warrants

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Jun 25, 2025, 10:40 AM EDT - 6 months ago

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 25, 2025, 8:30 AM EDT - 6 months ago

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Jun 12, 2025, 9:05 AM EDT - 6 months ago

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 4, 2025, 8:30 AM EDT - 7 months ago

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 28, 2025, 8:30 AM EDT - 7 months ago

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

May 20, 2025, 8:30 AM EDT - 7 months ago

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 14, 2025, 5:10 PM EDT - 8 months ago

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

May 13, 2025, 8:01 AM EDT - 8 months ago

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Apr 16, 2025, 8:00 AM EDT - 9 months ago

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Apr 3, 2025, 8:01 AM EDT - 9 months ago

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 31, 2025, 5:00 PM EDT - 9 months ago

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Mar 19, 2025, 8:01 AM EDT - 10 months ago

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Feb 26, 2025, 8:01 AM EST - 10 months ago

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Feb 4, 2025, 12:24 PM EST - 11 months ago

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Feb 4, 2025, 8:01 AM EST - 11 months ago

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Jan 29, 2025, 9:00 AM EST - 11 months ago

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Glucotrack Announces ISO 13485:2016 Certification

Jan 21, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces ISO 13485:2016 Certification

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Jan 15, 2025, 8:01 AM EST - 1 year ago

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Glucotrack to Present at TechBio Showcase™ 2025

Jan 7, 2025, 4:05 PM EST - 1 year ago

Glucotrack to Present at TechBio Showcase™ 2025

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Dec 3, 2024, 8:30 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

Nov 14, 2024, 4:30 PM EST - 1 year ago

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

Oct 22, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

Oct 1, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Sep 3, 2024, 9:00 AM EDT - 1 year ago

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

Aug 15, 2024, 9:00 AM EDT - 1 year ago

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

Aug 5, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Jun 20, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

Jun 13, 2024, 9:19 AM EDT - 1 year ago

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

Jun 10, 2024, 10:50 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Jun 5, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

May 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

May 15, 2024, 4:15 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

May 2, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Apr 22, 2024, 2:10 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

Apr 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Apr 2, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

Mar 12, 2024, 9:30 AM EDT - 1 year ago

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Feb 27, 2024, 8:30 AM EST - 1 year ago

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS

Feb 13, 2024, 9:30 AM EST - 2 years ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS

GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Jan 2, 2024, 12:33 PM EST - 2 years ago

GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

Nov 30, 2023, 5:39 PM EST - 2 years ago

GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

BillionerOfKing
BillionerOfKing Dec. 25 at 3:05 AM
$GCTK Current Stock Price: $4.49
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 24 at 12:40 PM
$GCTK will need u shortly * due to MWG shenanigans im pullingall mornign with beloved
0 · Reply
Stay_Tuned_
Stay_Tuned_ Dec. 23 at 1:09 PM
$GCTK I was a believer. Maybe still am but they need money in Q1, time running short for this to pop before needed dilution. Out for now will watch from sidelines.
0 · Reply
FullPorrtDipz
FullPorrtDipz Dec. 23 at 2:02 AM
If you like getting in them before the massive moves.. Drop @MomentumZeus a FOLLOW below. He's been calling some insane runners lately.. 🚀 Always buying positions on $GCTK $SNTI $RUBI $CTM
0 · Reply
FloatGlowCore_1416
FloatGlowCore_1416 Dec. 16 at 12:34 PM
$GCTK microcap biotech, narrow range and low float, one decent data point plus volume can send it
0 · Reply
Joby099
Joby099 Dec. 11 at 11:50 PM
$BDRX $AFJK $GCTK $ATGL $SOUN
0 · Reply
Tradr1205
Tradr1205 Dec. 11 at 3:05 PM
$GCTK Bought some more in premarket at $5.61. This baby is going to explode!
1 · Reply
Joby099
Joby099 Dec. 11 at 2:09 PM
$BDRX $AFJK $GCTK $ATGL $SOUN
0 · Reply
Jingbob
Jingbob Dec. 11 at 11:46 AM
$GCTK keep buying, the squeeze is coming
2 · Reply
BLD33
BLD33 Dec. 11 at 9:11 AM
$GCTK no shares to Short Cover coming !!!
1 · Reply
Mahdinur
Mahdinur Dec. 11 at 4:01 AM
$GCTK $CV $PAPL $GRI $GEMI $GRI low volume? Check again No catalyst? https://finviz.com/news/251086/gri-bio-announces-positive-topline-data-from-its-phase-2a-study-in-idiopathic-pulmonary-fibrosis-ipf
0 · Reply
BearTamerTrading
BearTamerTrading Dec. 11 at 3:50 AM
🌙 After-Hours Alerts — Bear Tamer Trading 🔥 $GCTK — Strong AH continuation on thin-float momentum; no new catalyst released. 🔥 $CV — Huge AH surge from aggressive buying pressure; no confirmed news across major outlets. 🔥 $PAPL — Volatile swings with sharp fades; no fresh filings or PR today. 🔥 $GRI — Low-volume biotech drift with a late bounce; no catalyst reported. 🔥 $GEMI — Clean AH push as space-sector specs rotated; no official news posted. Congrats to all BTT members who caught these plays tonight 💰🔥 Replay here ⬇️ https://www.youtube.com/live/9haq08DQdh0?si=pN4IRxtL4pYdWYWk 🚀 Rest up — we run it back tomorrow.
3 · Reply
ProfessorDman1
ProfessorDman1 Dec. 11 at 1:12 AM
Tomorrow WL: look for buy entry level above support or resistance break on volume … $SVRE $LGHL $JFBR $STKH $GCTK
3 · Reply
Tradr1205
Tradr1205 Dec. 10 at 11:32 PM
$GCTK Just loaded up!!!
0 · Reply
Joby099
Joby099 Dec. 10 at 11:26 PM
$BDRX $AFJK $GCTK $ATGL $SOUN Spot on!! https://www.youtube.com/watch?v=u5ie5NZm0CM
0 · Reply
JessicaLind
JessicaLind Dec. 10 at 11:19 PM
Buyers stepping into $CVKD—nice to see. $PL $GCTK $SNPS $ENVB
1 · Reply
topstockalerts
topstockalerts Dec. 10 at 11:07 PM
After Hours Top Gainers $CV $GEMG $GCTK $MOVE.X $GEMI
1 · Reply
Aburose
Aburose Dec. 10 at 10:54 PM
$GCTK believe or not news coming
0 · Reply
johnday888
johnday888 Dec. 10 at 10:52 PM
$GCTK risky now?
0 · Reply
johnday888
johnday888 Dec. 10 at 10:52 PM
$GCTK well it died
0 · Reply
Aburose
Aburose Dec. 10 at 10:50 PM
$GCTK if trades over 8.50 there some + news
0 · Reply
mcrotary
mcrotary Dec. 10 at 10:50 PM
$GCTK load
0 · Reply